  GTC  Biotherapeutics (Framingham,   MA, 

) and LFB  Biotechnologies (France) have signed an agreement to collaborate in the development  of selected recombinant plasma proteins and monoclonal antibodies using GTC’s  transgenic production platform. A joint steering committee will agree on  product development and commercialization plans.

News

GTC Biotherapeutics (Framingham, MA, http://www.gtc-bio.com) and LFB Biotechnologies (France) have signed an agreement to collaborate in the development of selected recombinant plasma proteins and monoclonal antibodies using GTC's transgenic production platform.